P/E ratio for DexCom (DXCM)

P/E ratio history for DexCom from 2005 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Edwards Lifesciences EW	30.1	-57.38%	🇺🇸 USA
Becton Dickinson BDX	36.4	-48.47%	🇺🇸 USA
West Pharmaceutical WST	28.3	-59.95%	🇺🇸 USA
Tandem Diabetes Care TNDM	-5.48	-107.76%	🇺🇸 USA
Medtronic MDT	30.3	-57.13%	🇮🇪 Ireland
Abbott Laboratories ABT	42.5	-39.89%	🇺🇸 USA
Johnson & Johnson JNJ	10.9	-84.56%	🇺🇸 USA
QuidelOrtho QDEL	133	87.99%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.